Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patientsA C Regierer, R Wolters, M-P Ufen, et al.
The International Journal of Biological Markers|July 27, 2001
Biomarkers and imaging in non-malignant and malignant osteomalaciaD Lüftner, M Bollow, A Stürzenbecher, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2000
Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapyT Beinert, D Binder, C Oehm, et al.
Pneumologie (Stuttgart, Germany)|June 24, 2000
[Oxidative pulmonary stress in cytoreductive therapy]T Beinert, D Binder, M Stuschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphomaA H Meyer, A Stroux, K Lerch, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
Endocrine treatment options for advanced breast cancer--the role of fulvestrantJ F R Robertson, S E Come, S E Jones, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.
European Journal of Medical Research|September 3, 1999
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?T Beinert, D Binder, C Oehm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-upA R Zander, C Schmoor, N Kröger, et al.
Studies in Health Technology and Informatics|December 8, 1996
Quality monitoring, standardized documentation and management with a computerized system in oncologyT Beinert, M Dubiel, H G Mergenthaler, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patientsA C Regierer, R Wolters, M-P Ufen, et al.
The International Journal of Biological Markers|July 27, 2001
Biomarkers and imaging in non-malignant and malignant osteomalaciaD Lüftner, M Bollow, A Stürzenbecher, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2000
Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapyT Beinert, D Binder, C Oehm, et al.
Pneumologie (Stuttgart, Germany)|June 24, 2000
[Oxidative pulmonary stress in cytoreductive therapy]T Beinert, D Binder, M Stuschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphomaA H Meyer, A Stroux, K Lerch, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
Endocrine treatment options for advanced breast cancer--the role of fulvestrantJ F R Robertson, S E Come, S E Jones, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.
European Journal of Medical Research|September 3, 1999
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?T Beinert, D Binder, C Oehm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-upA R Zander, C Schmoor, N Kröger, et al.
Studies in Health Technology and Informatics|December 8, 1996
Quality monitoring, standardized documentation and management with a computerized system in oncologyT Beinert, M Dubiel, H G Mergenthaler, et al.
Pageof 17